Welcome to the European Association for Cancer Research
Connecting cancer researchers together
LIF As We Know It: From Basic Science to Clinical Trials
Barcelona, Spain : 28 - 29 May 2018
Scientific Programme
.png)
FULL PROGRAMME AND SPEAKER ABSTRACTS
Click here to download the Full Programme and Abstract Book for the conference.
Registration
Foyer of VHIO
WELCOME LUNCH
Conference Introduction
Cellex Auditorium
Session 1 - LIF in cancer I
Chair: Joan Seoane
Joan Seoane VHIO, Spain
"Immunomodulatory role of LIF in cancer"
Cédric Gaggioli IRCAN, France
"A journey into the tumor microenvironment: a LIF(e) story"
Wenwei Hu Rutgers Cancer Institute, USA
"LIF, a Friend or Foe – its role in reproduction and cancer"
COFFEE BREAK
Session 2 - Early phase clinical trials
Chair: Joan Seoane
José Baselga MSKCC, USA
"Update on clinical development of anti-LIF antibodies as cancer therapy"
Lillian Siu University of Toronto, Canada
"Incorporating predictive biomarker development in first-in-class phase I trials – myth or must?"
Josep Tabernero VHIO, Spain
"New development strategies in Immuno-Oncology"
Bus to Evening Reception
Evening Reception
Hotel Alimara
All participants are invited to join this networking event. Drinks and hors d'oeuvres will be served in the garden of the hotel. The event will finish at 20:30, and the rest of the evening is free for you to enjoy Barcelona.
Session 3 - LIF in cancer II
Chair: Tony Hunter
Tony Hunter Salk Institute, USA
"LIF produced by stromal cells is a paracrine factor acting on tumor cells in pancreatic cancer"
Benjamin Neel NYU School of Medicine, USA
"Targeting SHP2 in cancer"
Peter Heinrich Albert-Ludwig University, Germany
"IL-6 type cytokines: signaling through the gp130-JAK-STAT pathway and its regulation"
COFFEE BREAK
Andrew Lowy UCSD, USA
"Identifying novel targets for pancreatic cancer therapy"
Manuel Serrano IRB Barcelona, Spain
"Critical role of the LIF-family of cytokines during the early phases of reprogramming into pluripotency"
LUNCH
Session 4 - LIF in inflammation
Chair: Su Metcalfe
Su Metcalfe University of Cambridge, UK
"NanoBioMedicine: Nano-formulation of LIF to treat Multiple Sclerosis, an inflammatory autoimmune disease of the CNS"
Niels Hellings Hasselt University, Belgium
"IL-6 class cytokines are master regulators of neuroimmunological disease"
Keith Pennypacker University of Kentucky, USA
"Age-related differences in the response to Leukemia Inhibitory Factor after experimental stroke"
General conclusions & Award presentation
Joan Seoane Scientific Organiser
COFFEE & FINAL NETWORKING
Until 17:00
Key dates
Travel Grant application deadline:
26 March 2018
Registration and Payment deadline:
30 April 2018
